Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

C., Graffander, P., Chen, R. T.: The timing of hepatitis B immunization and risk of insulin dependent diabetes mellitus. Pharmacoepidemiology and Drug Safety 1997, 6 (S2): S60
    DeStefano, F., Mullooly, J. P., Okoro, C. A., Chen, R. T.: Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001, 108 (6): E112
    DeStefano, F., Gu, D., Kramarz, P., Truman, B. I., et al.: Childhood vaccinations and risk of asthma. Pediatr Infect Dis J 2002, 21 (6): 498–504
    Devin, F., Roques, G., Disdier, P., Rodor, F., Weiller, P. J.: Occlusion of central vein after hepatitis B vaccination. Lancet 1996, 347 (9015): 1626
    Digiusto, C. A., Bernhard, J. D.: Erythema nodosum provoked by hepatitis B vaccine. Lancet 1986, 2 (8514): 1042
    EB (Epidemiologisches Bulletin): Virushepatitis B, C und D im Jahr 2002. EB 2004, 2: 11–17
    EB (Epidemiologisches Bulletin): Virushepatitis B, C und D im Jahr 2005. EB 2006, 46: 399–407
    EB (Epidemiologisches Bulletin): Virushepatitis B, C und D im Jahr 2010. EB 2011, 29: 261–271
    ECG (European Consensus Group on Hepatitis B Immunity): Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000, 355: 561–565
    Faure, E.: Multiple sclerosis and hepatitis B vaccination: Could minute contamination of the vaccine by partial Hepatitis B virus polymerase play a role through molecular mimicry? Med Hypotheses 2005, 65 (3): 509–520
    Fourrier, A., Touze, E., Alperovitch, A., et al.: Association between hepatitis B vaccine and multiple sclerosis: a case-control study. Pharmacoepidemiol Drug Saf 1999, 8 (Suppl): 140f.
    Fried, M., Conen, D., Conzelmann, M., Steinemann, E.: Uveitis after hepatitis B vaccination. Lancet 1987, 2 (8559): 631f.
    Geier, D. A., Geier, M. D.: A one year follow-up of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System ( VAERS ) database. Clin Exp Rheumatol 2002a, 20 (6): 767–771
    Geier, D. A., Geier, M. R.: Chronic adverse reactions associated with hepatitis B vaccination. Ann Pharmacother 2002b, 36: 1970f.
    Geier, M. R., Geier, D. A., Zahalsky, A. C.: A review of hepatitis B vaccination. Expert Opin Drug Saf 2003, 2 (2):113–122
    Gherardi, R. K.: Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome. Rev Neurol 2003, 159 (2): 162ff.
    Girard, M.: Report criticizes French hepatitis vaccination campaign. 7.11.2004. http:// www.rolandsimion.org/spip.php?article14&lang=fr (Zugriff 11. 1. 2012)
    Girard, M.: Allgemeine Hepatitis-B-Impfung – Was können wir aus den Erfahrungen Frankreichs lernen? 2005a. http:// www.impfo.ch/pdf-dokumente/GirardM_RedFlag_ HBV -I+ MS .pdf (Zugriff 12. 1. 2012)
    Girard, M.: Autoimmune hazards of hepatitis B vaccine. Autoimmun Review 2005b, 4 (2): 96–100
    Girard, M., Comenge, Y.: Multiple sclerosis and hepatitis B vaccination: adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence. Med Hypotheses 2006, 66 (1): 84ff.
    Goolsby, L. P. G.: Erythema nodosum after Recombivax HB hepatitis B vaccine. N Engl J Med 1989, 321: 1198–1199
    Grotto, I., et al.: Major adverse reactions to yeast-derived hepatitis B vaccine – a review. Vaccine 1998, 16: 329–334
    Gruis, K. L., Teener, J. W., Blaivas, M.: Pediatric macrophagic myofasciitis associated with motor delay. Clin Neuropathol 2006, 25 (4): 172–179
    Guiserix, J.: Systemic lupus erythematosus following hepatitis B vaccine. Nephron 1996, 74 (2): 441
    Hachulla, E., et al.: Reactive arthritis after hepatitis B vaccination. Journal of Rheumatology 1990, 17: 1250–1251
    Hamard, H., Hamard, P., Gohier, P., Roussat, B., Doummar, D., Iba-Zizen, M. T.: »Idiopathic« acute optic neuropathies in children. Bull Acad Natl Med 2000, 184 (7): 1511
    Hammitt, L. L., Hennessy, T. W., Fiore, A. E., Zanis, C., et al.: Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years. Vaccine 2007, 25 (39–40): 6958–6964
    Harle, J. R., Jouglard, J., Weiller, P. J. K.: Occlusion of the central retinal vein after vaccination against viral Hepatitis B with recombinant vaccines. 4 cases. Presse Medicale 1997, 26 (2): 62–65
    Hartmann, K., Keller-Stanislawski, B.: Rekombinante Hepatitis-B-Impfstoffe und Verdachtsfälle unerwünschter Reaktionen. Bundesgesundheitsbl – Gesundheitsforsch –